NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.34
-0.39 (-3.10%)
Dec 5, 2025, 4:00 PM EST - Market closed
NextCure Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 42 | 22 | 32 | 39 | 166 | 300 | |
| Market Cap Growth | 13.92% | -32.12% | -18.77% | -76.37% | -44.81% | -80.57% | |
| Enterprise Value | 18 | -48 | -80 | -130 | -70 | 13 | |
| Last Close Price | 12.34 | 9.25 | 13.68 | 16.92 | 72.00 | 130.80 | |
| PS Ratio | - | - | - | - | - | 13.42 | |
| PB Ratio | 1.40 | 0.33 | 0.28 | 0.23 | 0.71 | 1.02 | |
| P/TBV Ratio | 1.77 | 0.33 | 0.28 | 0.23 | 0.71 | 1.02 | |
| EV/Sales Ratio | - | - | - | - | - | 0.58 | |
| Debt / Equity Ratio | 0.23 | 0.09 | 0.06 | 0.04 | - | 0.01 | |
| Asset Turnover | - | - | - | - | - | 0.07 | |
| Quick Ratio | 2.68 | 7.20 | 15.85 | 17.60 | 33.23 | 27.45 | |
| Current Ratio | 2.97 | 7.50 | 16.38 | 17.97 | 34.48 | 27.89 | |
| Return on Equity (ROE) | -116.91% | -61.87% | -44.49% | -37.28% | -26.33% | -11.90% | |
| Return on Assets (ROA) | -58.01% | -34.23% | -27.08% | -22.25% | -16.11% | -7.78% | |
| Return on Capital (ROIC) | -68.08% | -37.16% | -28.59% | -23.25% | -16.67% | -8.26% | |
| Return on Capital Employed (ROCE) | -210.80% | -80.20% | -55.80% | -43.40% | -30.00% | -13.90% | |
| Earnings Yield | -138.80% | -257.74% | -197.18% | -190.83% | -41.86% | -12.19% | |
| FCF Yield | -117.03% | -191.17% | -169.11% | -143.00% | -35.98% | -17.34% | |
| Buyback Yield / Dilution | -4.40% | -0.46% | -0.33% | -0.46% | -0.30% | -75.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.